Todd C. Brady
2020
In 2020, Todd C. Brady earned a total compensation of $2.4M as President and Chief Executive Officer at Aldeyra Therapeutics, a 42% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $299,129 |
|---|---|
| Option Awards | $621,962 |
| Salary | $543,871 |
| Stock Awards | $945,000 |
| Other | $11,400 |
| Total | $2,421,362 |
Brady received $945K in stock awards, accounting for 39% of the total pay in 2020.
Brady also received $299.1K in non-equity incentive plan, $622K in option awards, $543.9K in salary and $11.4K in other compensation.
Rankings
In 2020, Todd C. Brady's compensation ranked 4,703rd out of 13,090 executives tracked by ExecPay. In other words, Brady earned more than 64.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,703 out of 13,090 | 64th |
Division Manufacturing | 1,910 out of 5,621 | 66th |
Major group Chemicals And Allied Products | 749 out of 2,254 | 67th |
Industry group Drugs | 643 out of 1,954 | 67th |
Industry Pharmaceutical Preparations | 487 out of 1,459 | 67th |
Source: SEC filing on April 25, 2022.
Brady's colleagues
We found one more compensation record of an executive who worked with Todd C. Brady at Aldeyra Therapeutics in 2020.
2020
Joshua Reed
Aldeyra Therapeutics
Chief Financial Officer
News
Aldeyra Therapeutics CEO Todd Brady's 2023 pay jumps 29% to $3.7M
April 22, 2024
Aldeyra Therapeutics CEO Todd Brady's 2022 pay slips 17% to $2.9M
May 23, 2023
Aldeyra Therapeutics CEO Todd Brady's 2021 pay jumps 43% to $3.5M
April 25, 2022
Aldeyra Therapeutics CEO Todd Brady's 2019 pay jumps 44% to $4.1M
April 27, 2020
Aldeyra Therapeutics CEO Todd Brady's 2018 pay jumps 21% to $2.9M
April 22, 2019